CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0042-1742319
Case Report with Review of Literature

Extra-Nodal Follicular Dendritic Cell Sarcoma with Unusual Morphological Features and PDL1 Expression

Manali Ranade
1   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Aekta Shah
1   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Subhash Yadav
1   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
2   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations

Abstract

Follicular dendritic cell (FDC) sarcoma, a rare tumor of FDCs, poses a diagnostic challenge due to its myriad morphologic and architectural patterns. We present a unique case of extra-nodal FDC sarcoma occurring in a 28-year-old gentleman who presented with multiple pelvic, peritoneal and retroperitoneal soft tissue, and axial skeletal lesions. The tumor was composed of islands and trabeculae of epithelioid cells with interspersed lymphocytes against a background of abundant myxoid matrix. On immunohistochemistry, in addition to the CD21, the tumor was positive for GATA3, inhibin, and programmed death-ligand 1 (PDL1), which have been rarely reported previously in FDC sarcoma. The patient underwent surgical excision of the tumor and was later offered immunotherapy. He has been disease-free for 2 years following immunotherapy. Our case highlights the potential role of immune checkpoint inhibitors in treating FDC sarcoma, which show immuno-expression of PDL1.

Declaration of Patient Consent

The authors certify that they have obtained all appropriate patient consent forms.


Supplementary Material



Publication History

Article published online:
26 April 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. Am J Pathol 1986; 122 (03) 562-572
  • 2 Ioachim H, Medeiros L. Granulocytic, histiocytic, and dendritic cell neoplasms. In: Ioachim's Lymph Node Pathology. 4th edition. Philadelphia, PA: Wolters Kluwer; 2009: 531-535
  • 3 van Nierop K, de Groot C. Human follicular dendritic cells: function, origin and development. Semin Immunol 2002; 14 (04) 251-257
  • 4 Chan J, Pileri S, Fletcher C, Weiss L, Grogg K. Follicular dendritic cell sarcoma. In: Swerdlow S, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, Thiele J. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised. 4th edition. Lyon, France: IARC Press; 2017: 476-478
  • 5 Kaur R, Mehta J, Borges A. Extranodal follicular dendritic Cell sarcoma-A review: “what the mind does not know the eye does not see”. Adv Anat Pathol 2021; 28 (01) 21-29
  • 6 Li L, Shi YH, Guo ZJ. et al. Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma. World J Gastroenterol 2010; 16 (20) 2504-2519
  • 7 Pang J, Mydlarz WK, Gooi Z. et al. Follicular dendritic cell sarcoma of the head and neck: case report, literature review, and pooled analysis of 97 cases. Head Neck 2016; 38 (Suppl. 01) E2241-E2249
  • 8 Lee MY, Bernabe-Ramirez C, Ramirez DC, Maki RG. Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab. BMJ Case Rep 2020; 13 (04) e234363
  • 9 Okada K, Takahara T, Suzuki Y. et al. Histiocytic and dendritic cell neoplasms: reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression. Pathol Int 2021; 71 (01) 24-32
  • 10 Xu J, Sun HH, Fletcher CD. et al. Expression of programmed cell death 1 ligands (PD-L1 and PD-L2) in histiocytic and dendritic cell disorders. Am J Surg Pathol 2016; 40 (04) 443-453
  • 11 Agaimy A, Michal M, Hadravsky L, Michal M. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1. Ann Diagn Pathol 2016; 23: 21-28
  • 12 Chan JKC. Proliferative lesions of follicular dendritic cells. Adv Anat Pathol 1997; 4: 387-411
  • 13 Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996; 20 (08) 944-955
  • 14 Lorenzi L, Lonardi S, Petrilli G. et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol 2012; 43 (02) 209-215
  • 15 Li XQ, Cheuk W, Lam PW. et al. Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions. Am J Surg Pathol 2014; 38 (05) 646-653
  • 16 Fisher C, Magnusson B, Hardarson S, Smith ME. Myxoid variant of follicular dendritic cell sarcoma arising in the breast. Ann Diagn Pathol 1999; 3 (02) 92-98
  • 17 Zhang H, Maitta RW, Bhattacharyya PK. et al. γ-Synuclein is a promising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors. Am J Surg Pathol 2011; 35 (12) 1857-1865
  • 18 Lavinia PM, Ryan WHL, Jeffrey M, Roberto NM. Follicular dendritic cell sarcoma in the differential diagnosis of GATA3 positive tumors: a case report. Hum Pathol 2021; 23: 2214-3300
  • 19 Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 2000; 13 (05) 577-585
  • 20 Wu A, Pullarkat S. Follicular dendritic cell sarcoma. Arch Pathol Lab Med 2016; 140 (02) 186-190
  • 21 Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997; 79 (02) 294-313
  • 22 Maleki Vareki S. High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors. J Immunother Cancer 2018; 6 (01) 157
  • 23 Bonaventura P, Shekarian T, Alcazer V. et al. Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol 2019; 10: 168
  • 24 Emens LA. Breast cancer immunotherapy: facts and hopes. Clin Cancer Res 2018; 24 (03) 511-520
  • 25 Ren W, Sun Q, Wu PY. et al. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: a case report. Medicine (Baltimore) 2018; 97 (48) e13413
  • 26 Cingam SR, Al Shaarani M, Takalkar A, Peddi P. Follicular dendritic sarcoma masquerading as fibrosing mediastinitis. BMJ Case Rep 2017; bcr2016218889